Moreover, De and Michor 1 provide evidence supporting replicative models of cancerpromoting genomic rearrangement. The analytical strategies presented in both studies should be useful for interpreting the wealth of new data on structural variation in cancer and other rearranged genomes, and for distinguishing the molecular mechanisms underlying genomic rearrangements.
interacting sequences. This relationship could mean either that a distance-dependent mechanism underlies SCNA formation or that there is selection against long SCNAs. Such negative selection is expected because longer deletions, which remove more genes, would be more detrimental to the cell, and longer amplifications slow growth rate proportionately, at least in bacteria 11 . The authors showed that including a parameter for negative selection against long SCNAs substantially improved the fit of SCNA data to the spatial proximity data.
Finally, and quite remarkably, De and Michor 1 used the Hi-C and replication timing data to predict the locations of 47% of the SCNAs in an independent data set of ovarian cancer SCNAs. This proportion is high considering that not all possible SCNAs occur in any given sample of cancers, and that some SCNAs are selected against because they inhibit tumor growth.
In summary, the results of De and Michor 1 and Fudenberg et al. 2 reveal properties of hot spots for genome rearrangement in cancers. These hot spots are three-dimensionally proximal and simultaneously replicating sites that, when recombined, produce rearrangements that do not impede and may promote tumor growth.
The finding that two regions are more likely to recombine if they are replicated simultaneously implies that such SCNAs form by mechanisms other than homologous recombination. In homologous recombination, only one of the recombining molecules must be single stranded to allow binding of a RecA-like protein 8 . The creation of this single-stranded end is thought to depend on DNA replication (or possibly transcription 9 ). The RecA-coated singlestranded end invades a homologous partner molecule that is double stranded, not single stranded or broken. Thus, homologous recombination ought to require replication of one but not both of the recombining sites. Interestingly, for 32% of the SCNA boundaries examined by De and Michor 1 , the recombining sites replicated at different times. This 32% might correspond to SCNAs generated by homologous recombination, which are often ~30% of the total 5 , indicating again how informative it would be to separate the SCNAs generated by homologous and nonhomologous recombination in future bioinformatic analyses.
The results of De and Michor's 1 study support recent models of SCNA formation that involve DNA replication (e.g., microhomologymediated break-induced replication and the long-distance template switch model, also called FoSTeS) 8 , and are less supportive of other nonhomologous recombination mechanisms such as nonhomologous end joining 8 , which has been widely cited as possibly underlying the formation of SCNAs ( Fig. 1) . In microhomologymediated break-induced replication, replication is restarted from a collapsed replication fork on a single-stranded template. It requires both a double-stranded end at one site and singlestranded DNA at the other, whereas nonhomologous end joining requires two double-stranded ends, one at each site. Because double-stranded ends form rarely during replication (e.g., in <1% of replications of the 4.6 Mb Escherichia coli genome 10 ), the two ends required for nonhomologous end joining are much less likely to occur than the single end required for microhomology-mediated break-induced replication. Further supporting a replication-based mechanism is the finding that replication proteins are required for SCNA formation, at least in bacteria (reviewed 8 ) , although the open chromatin structure in replicating DNA might promote recombination by any mechanism.
In addition to proximity in the nucleus and common replication timing, Fudenberg et al. 2 suggest a third contributor to SCNA site distribution: selection against long SCNAs within a chromosome arm. They found that, within a chromosome arm, both Hi-C contact probability and SCNA length show very similar exponential decline with distance from the Ubiquitination is not just about targeting proteins for degradation in the proteasome. Many properties of proteins, such as their localization, binding partners and activity, are controlled by adding and removing ubiquitin tags through an enzymatic machinery whose complexity rivals that of phosphorylation. Yet few ubiquitination sites have been identified compared with the number of known phosphorylation sites, in large part because of a lag in the development of suitable high-throughput technologies. Three recent reports in Molecular Cell 1 , Molecular Cellular Proteomics 2 and Cell 3 have now remedied this situation. Taken together, the papers provide a comprehensive view of ubiquitination sites and reveal the functional consequences of ubiquitination for a large subset of the human proteome.
Ubiquitination is a post-translational modification in which ubiquitin, a 76-amino acid protein, is covalently added to lysine residues 4 . In humans, the ubiquitination reaction is catalyzed by >500 E3 ligases 5 , each of which transfers ubiquitin to specific protein targets. There are several types of ubiquitin modification, and these may have different effects on target proteins. The best known is the polyubiquitin chain, which targets proteins for proteasomal degradation. The polyubiquitin chain begins with a ubiquitin conjugated at its C terminus to the ε-amine of a lysine residue in a target protein. Subsequent ubiquitins in the chain are conjugated to a lysine residue in the previous ubiquitin, typically through the level of ubiquitination at each lysine in a protein is influenced by protea some inhibitors. In many cases, the ubi quitination of specific lysines increased, suggesting that ubiquitination of these sites leads to proteasomal degradation. Surprisingly, for some ubiquitination sites, proteasome inhibitor treatment reduced ubiquitin levels. Ubiquitination of these lysines is probably linked to functions other than proteasomal degradation. As these sites are presumably subject to physiological cycles of ubiquitination and deubiquitination, ubiquitination levels drop when the released ubiquitin is sequestered in proteins that would otherwise have been degraded by the proteasome. Thus, proteasome inhibition studies allow ubiquitination sites to be classified as having a proteasome-dependent or proteasome-independent role. Kim et al. 1 and Emanuele et al. 3 also applied ubiquitin remnant profiling to discover targets of E3 ligases. E3 ligases are potential drug targets, although determining which ones are suitable targets depends on identifying the specific proteins that they ubiquitinate. Both groups used MLN4924, an inhibitor of cullin-RING ubiquitin ligases, to identify several experiments to study ubiquitination functions. One solution might be to include protein-synthesis inhibitors in future proteomics experiments to reduce the numbers of quality-control sites. Alternatively, one could screen for ubiquitination sites that are induced in a signal-dependent manner. Carefully annotated databases will be needed to help researchers distinguish ubiquitination events involved in cellular housekeeping and in signaling functions. As Kim et al. 1 note, ubiquitination sites on nascent misfolded proteins could be valuable biomarkers of cellular states in which protein synthesis or protein folding has been disrupted, as seen in conditions such as Alzheimer's and Parkinson's disease.
Determining the functional consequences of ubiquitination is still a major challenge in the field. Protein degradation can in principle be detected by monitoring increases in protein levels after proteasome inhibition. However, these experiments can be inconclusive as ubiquitination may target the protein only in a specific cellular compartment, resulting in no overall change in protein levels. Both Kim et al. 1 and Wagner et al. 2 
address this problem by studying how
Lys48, thereby forming a signal for proteasomal degradation 6 . Polyubiquitin chains that are linked through other lysines may have functions unrelated to the proteasome, such as altering protein subcellular localization or interactions 7 . Another form of ubiquitination is monoubiquitination, in which only one ubiquitin is attached to a target protein.
Monoubiquitination can alter subcellular localization. The variety of ubiquitin modifications accounts for the diverse effects of ubiquitination on protein function.
To identify ubiquitinated proteins and the modified lysine residues, Kim et al. 1 , Wagner et al. 2 and Emanuele et al. 3 used a mass spectrometry-based approach developed in our laboratory known as ubiquitin remnant profiling 8 . In proteomic methods for analyzing other post-translational modifications, such as phosphorylation and acetylation, the target sequences are pulled out using antibodies specific to the modification. In contrast, ubiquitin remnant profiling relies on antibodies that recognize a protein modification generated after a ubiquitinated protein is digested with trypsin ( Fig. 1a) 8 . The C-terminal residues of ubiquitin are Arg-Gly-Gly; cleavage of ubiquitin after arginine leaves a diglycine remnant attached to the modified lysine residues in proteins. Antibodies specific for diglycine-modified lysines do not precipitate free ubiquitin but precipitate ubiquitin remnant-containing peptides from tryptic digests, allowing these peptides to be analyzed by mass spectrometry 8 .
Wagner et al. 2 and Kim et al. 1 applied ubiquitin remnant profiling of human cells to generate the largest catalogs of ubiquitination sites to date. Using powerful mass spectro metry instrumentation, they identified ~11,000 (ref. 2) and ~19,000 (ref. 1) ubiquitination sites. Consistent with previous studies, these data sets revealed that a substantial number of proteins are ubiquitinated on multiple lysine residues, and that the ubiquitination status of each lysine residue can be independently regulated 1 .
A striking finding was that the majority of ubiquitination events in cells occurs on newly synthesized proteins 1 . Earlier investigations had shown that the proteasome acts largely on newly synthesized proteins, which are particularly susceptible to aggregation and misfolding 9 . In accordance with this idea, Kim et al. 1 found that the level of ubiquitination at >70% of ubiquitinated sites dropped significantly after inhibition of protein synthesis.
These results indicate that catalogs of ubiquitination sites may contain large numbers of 'quality-control' sites rather than 'regulatory' sites with roles in cellular signaling pathways (Fig. 1b) . This issue should be considered when using these catalogs to design mutagenesis Figure 1 Ubiquitin remnant profiling to identify protein ubiquitination sites. (a) In ubiquitin remnant profiling, ubiquitin remnants are revealed after trypsin digestion of lysates. Trypsin cleaves ubiquitin after an arginine residue near its C terminus, leaving a ubiquitin-derived diglycine remnant on lysine residues in target proteins. Ubiquitin remnant-containing peptides are purified with a diglycyl-lysinespecific antibody. Mass spectrometry is used to sequence these peptides and identify the modified lysine residues. (b) Two classes of ubiquitination. Ubiquitination is often targeted to newly synthesized proteins, which are highly susceptible to misfolding and aggregation. This 'quality control' ubiquitination mechanism ensures that misfolded proteins undergo proteasomal degradation. In response to signaling or other pathways, properly folded proteins may be subject to 'regulatory' ubiquitination, which can target a protein for proteasomal degradation or otherwise influence protein function. therapeutic compounds. General application of this approach to other E3 ligases will undoubtedly uncover novel E3 ligase-regulated pathways and reveal E3 ligases that target diseaserelated proteins.
